Frontiers Case report: Short-term eculizumab use in atypical HUS
Por um escritor misterioso
Descrição
PDF] Pathogenesis of Atypical Hemolytic Uremic Syndrome
Frontiers An ex vivo test to investigate genetic factors conferring susceptibility to atypical haemolytic uremic syndrome
Atypical Hemolytic Uremic Syndrome: New Challenges in the Complement Blockage Era
PDF) Successful use of eculizumab to treat atypical hemolytic uremic syndrome in patients with inflammatory bowel disease
Frontiers Case Report: Variable Pharmacokinetic Profile of Eculizumab in an aHUS Patient
Frontiers Case Report: Tackling Complement Hyperactivation With Eculizumab in Atypical Hemolytic Uremic Syndrome Triggered by COVID-19
PDF) A systematic review on the efficacy and safety of eculizumab for atypical hemolytic uremic syndrome
PDF) Long-term remission of atypical HUS with anti-factor H antibodies after cyclophosphamide pulses
PDF) Thrombotic Microangiopathy After Kidney Transplantation: An Underdiagnosed and Potentially Reversible Entity
PDF) Eculizumab use in a tertiary care nephrology center: data from the Vienna TMA cohort
de
por adulto (o preço varia de acordo com o tamanho do grupo)
